|
"rees c"的相關文件
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2013-06-21 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
|
Roy, AC;Park, SR;Cunningham, D;Kang, YK;Chao, Y;Chen, LT;Rees, C;Lim, HY;Tabernero, J;Ramos, FJ;Kujundzic, M;Cardic, MB;Yeh, CG;De Gramont, A |
| 國立成功大學 |
2013-06 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
|
Roy, A. C.; Park, S. R.; Cunningham, D.; Kang, Y. K.; Chao, Y.; Chen, L. T.; Rees, C.; Lim, H. Y.; Tabernero, J.; Ramos, F. J.; Kujundzic, M.; Cardic, M. B.; Yeh, C. G.; de Gramont, A. |
| 國家衛生研究院 |
2011-02 |
Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma
|
Cunningham, D;Park, S;Kang, Y;Chao, Y;Chen, L;Rees, C;Lim, H;Tabernero, J;Yeh, G;De Gramont, A |
顯示項目 1-3 / 3 (共1頁)
1
每頁顯示[10|25|50]項目
|
